Related Experiment Video

Updated: Aug 14, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Counselling issues in familial hypertrophic cardiomyopathy

B Yu1, J A French, R W Jeremy

  • 1Department of Molecular and Clinical Genetics, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Journal of Medical Genetics
|April 16, 1998
PubMed

Insights

Familial hypertrophic cardiomyopathy (FHC) shows variable clinical presentations and progression rates. Different genetic defects, like missense mutations versus protein truncating mutations, influence FHC penetrance and sudden cardiac death risk.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Familial hypertrophic cardiomyopathy (FHC) is a genetic disorder characterized by left ventricular hypertrophy.
  • Clinical presentations and disease progression in FHC are highly variable.
  • Understanding genotype-phenotype correlations is crucial for managing FHC.

Purpose of the Study:

  • To compare phenotypes and genotypes in three FHC families with distinct genetic defects.
  • To illustrate the variable clinical presentations and progression rates in FHC.
  • To investigate the impact of different mutation types on FHC penetrance.

Main Methods:

  • Comparative analysis of phenotypes and genotypes across three FHC families.
  • Identification of specific genetic mutations: Gln969X (protein truncating) and Asn755Lys (missense) in the cardiac myosin binding protein C gene.
  • Identification of a missense mutation (Arg453Cys) in the cardiac beta myosin heavy chain gene.

Main Results:

  • Protein truncating mutation (Gln969X) showed 27% penetrance (ages 0-40 years).
  • Missense mutations in the same gene exhibited significantly higher penetrance (93% ages 0-40 years).
  • Variable penetrance and unpredictable sudden cardiac death risk complicate FHC diagnosis and management.

Conclusions:

  • Genetic defects in FHC significantly influence disease penetrance and clinical outcomes.
  • Missense mutations are associated with higher penetrance compared to protein truncating mutations in FHC.
  • The variability in FHC necessitates tailored genetic counseling and clinical management strategies.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...